Eduardo Hernandez, MD

Dr. Hernandez is the President of The Texas Heart Institute Center for Cardiovascular Care and serves on the Medical Executive Committee of The Texas Heart Institute, overseeing the Professional Staff. He is involved in progressive clinical research, participating in numerous clinical trials in both coronary and peripheral vascular disease, antiplatelet therapy and antithrombotic therapy. Show full bio

Dr. Eduardo Hernandez has been a practicing cardiologist since 2000.  He completed his medical training at the University of Puerto Rico.  He then completed internship and residency training at the University of Alabama in Birmingham, followed by fellowships in Cardiology and Interventional Cardiology and Advanced Peripheral Vascular interventions at Baylor College of Medicine’s St. Luke’s Episcopal Hospital / Texas Heart Institute where he was elected to serve as the chief fellow.

In his clinical practice, he specializes in coronary and peripheral arterial disease – as well as venous disease – focusing on both medical and interventional management and he formerly served as the Medical Director at the Diagnostic Heart Center of St. Luke’s.

Dr. Hernandez has been recognized by numerous national organizations since graduating from his fellowship including Texas Monthly, Bridges to Excellence, the Heart/Stroke Recognition Program, and the Patient’s Choice Award.

He is a Clinical Associate Professor of Medicine at Baylor College of Medicine, Fellow of the American College of Cardiology, active member of the International Society of Endovascular Specialists, and past President of the Texas Heart Cardiac Society.

 

Eduardo A. Hernandez
Super Doctors
See Publications

Texas Heart Institute Positions

Interests

  • Cardiology
  • Interventional Cardiology

Education

  • Undergraduate:

    University of Puerto Rico, Rio Piedras, Puerto Rico

  • Medical School:

    University of Puerto Rico School of Medicine, San Juan, Puerto Rico

  • Internship:

    University of Alabama at Birmingham

  • Residency:

    University of Alabama at Birmingham

  • Fellowships:

    St. Luke’s Episcopal Hospital/Texas Heart Institute
    Cardiology/Interventional Cardiology and Advanced Peripheral Interventions

Academic & Clinical Affiliations

  • The Texas Heart Institute Center for Cardiovascular Care
  • Diagnostic Heart Center of St. Luke’s
  • Baylor College of Medicine
  • Methodist Hospital
  • Baylor St. Luke’s Medical Center Hospital
  • Editorial Board, Austin Journal of Women’s Health
  • Peer Review Board, Catheterization and Cardiovascular Interventions

Honors, Awards and Memberships

Publications

Angelini, P., Uribe, C. and Hernandez, E. (2022). Can ectopic right coronary from the left sinus have a different course than intramural? A case of ectopic right with retroaortic course. Cardiol Young, 1–3. https://doi.org/10.1017/S1047951121004947.
Angelini, P., Postalian, A., Hernandez-Vila, E. et al. (2022). COVID-19 and the heart: could transient takotsubo cardiomyopathy be related to the pandemic by incidence and mechanisms? Front Cardiovasc Med 9, 919715. https://doi.org/10.3389/fcvm.2022.919715.
Angelini, P., Muthupillai, R., Lopez, A. et al. (2021). Young athletes: Preventing sudden death by adopting a modern screening approach? A critical review and the opening of a debate. Int J Cardiol Heart Vasc 34, 100790. https://doi.org/10.1016/j.ijcha.2021.100790.
Galiñanes, E. L., Hernandez-Vila, E. A. and Krajcer, Z. (2019). EndoAnchors minimize endoleaks in chimney-graft endovascular repair of juxtarenal abdominal aortic aneurysms. Tex Heart Inst J 46, 183–188. https://doi.org/10.14503/THIJ-17-6520.
Millard, M. A. and Hernandez-Vila, E. A. (2018). What do the guidelines really say about aspirin? Tex Heart Inst J 45, 228–230. https://doi.org/10.14503/THIJ-18-6673.
McArdle, M. and Hernandez-Vila, E. A. (2017). Management of chronic venous disease. Tex Heart Inst J 44, 347–349. https://doi.org/10.14503/THIJ-17-6357.
Vasquez-Rios, G., Gamero, M. T., De la Cruz, J. et al. (2017). Insidious onset of intermittent claudication as the primary manifestation of infective endocarditis. Int J Gen Med 10, 11–14. https://doi.org/10.2147/IJGM.S113385.
Godley, R. W. and Hernandez-Vila, E. (2016). Aspirin for primary and secondary prevention of cardiovascular disease. Tex Heart Inst J 43, 318–319. https://doi.org/10.14503/THIJ-16-5807.
Galiñanes, E. L., Hernandez, E. and Krajcer, Z. (2016). Preliminary results of adjunctive use of endoanchors in the treatment of short neck and pararenal abdominal aortic aneurysms. Catheter Cardiovasc Interv 87, E154-159. https://doi.org/10.1002/ccd.26351.
Hernandez-Vila, E. (2015). A review of the JNC 8 blood pressure guideline. Tex Heart Inst J 42, 226–228. https://doi.org/10.14503/THIJ-15-5067.

Recent News

See All

THI Professional Staff Elects Surendra Jain, MD to the Institute’s Medical Executive Committee

At the annual meeting of The Texas Heart Institute Professional Staff on Tuesday, Dec. 5, 2023, elections were held by...

Read more

Remembering Dr. Paolo Angelini

The Texas Heart Institute family proudly honors the impressive life, esteemed career and lasting legacy of Dr. Paolo Angelini, who...

Read more

Beat the Heat with The Texas Heart Institute Center for Cardiovascular Care Live on Facebook

Are you ready to beat the heat and ignite the spark of curiosity within you? We are bringing a healthy...

Read more